Price to Sales ratio Analysis of Immuneering Corp - Deep Dive
Latest FY PS
Period Ending - Dec-23
Very Poor PS
91807341
Period Ending - Dec-22
Very Poor PS
122.38
Growth
75017953 %
Trailing Twelve Months PS
Period Ending - Dec-23
Very Poor PS
0
PS Analysis of Immuneering Corp
PS Ratio of IMRX rose handsomely by 75017953 % this year. |
PS Ratio of IMRX trending up for at least three Years. |
PS Ratio with value of 5.46 was lowest in Year Dec-20 in last Five Years. |
Latest PS Ratio with value of 91807341 is Greater than Average PS of 18361497 in last five years. |
Other PS Related Info of IMRX that may interest you.
Immuneering Corp Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
IMRX | 1.47 | 1.54 | 4.55 % | Biotechnology |
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions. more ..PS Related Ratios
PriceToBookRatio | PriceToEarningRatio | AssetTurnoverRatio |
Tsr Value Index
No Significant Value |
FY - Historical Price to Sales of Immuneering Corp
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
---|---|---|---|---|---|
PS | 91807341 | 122.38 | 9.62 | 5.46 | 6.57 |
Change | 75017953 % | 1172.08 % | 76.34 % | -16.95 % |
FY Chart of Price to Sales of Immuneering Corp
Note : All Data Generated at the End of Trading Hours (EOD Data)